Sort
15,440 grants matching “organoids”
Project 3: Systematic characterization of factors controlling breast cancer progression and resistance
$333,522Michael C Bassik · Stanford University · U54 · FY2025 · CA
A microengineered colon cancer-chip designed to investigate tumor-stromal interactions driving cancer progression
$333,481Shannon Michelle Mumenthaler · Ellison Institute, Llc · R01 · FY2024 · CA
Core 1: Biospecimens Core
$333,412Jann N Sarkaria · Massachusetts Institute Of Technology · U54 · FY2025 · CA
Novel therapeutics, models and immune interations for cryptosporidiosis
$333,346Richard L Guerrant · University Of Maryland Baltimore · U54 · FY2011 · AI
Bioengineered Multi-Cell Type Organoids For Airways Disease Modeling
$333,330Sean Vincent Murphy · Wake Forest University Health Sciences · R56 · FY2018 · HL
Aging and Telomere Dysfunction in the Intestinal Stem Cell Niche
$333,116Christopher Joachim Lengner · University Of Pennsylvania · R56 · FY2025 · AG
ADRD Induced pluripotent stem cell/organoid core
$333,036Lisa M. Ellerby · Buck Institute For Research On Aging · P01 · FY2025 · AG
Micro-capsule technology for high-throughput analyses of cell-cell interactions
$332,808Allon Moshe Klein · Harvard Medical School · R01 · FY2024 · GM
Single Cell/RNA-Seq dissection of Human iPS cell development into intestine
$332,775S Steven Potter · Cincinnati Childrens Hosp Med Ctr · R01 · FY2014 · DK
Single Cell/RNA-Seq dissection of Human iPS cell development into intestine
$332,775S Steven Potter · Cincinnati Childrens Hosp Med Ctr · R01 · FY2013 · DK
Single Cell/RNA-Seq dissection of Human iPS cell development into intestine
$332,775S Steven Potter · Cincinnati Childrens Hosp Med Ctr · R01 · FY2016 · DK
Single Cell/RNA-Seq dissection of Human iPS cell development into intestine
$332,775S Steven Potter · Cincinnati Childrens Hosp Med Ctr · R01 · FY2015 · DK
Mechanisms of resistance to endocrine therapy in ER positive breast cancer
$332,774Carlos L Arteaga · Vanderbilt University Medical Center · P50 · FY2021 · CA
Targeting the Mutant H3.3 Pathway in Glioma
$332,496Paul S Knoepfler · University Of California At Davis · R01 · FY2018 · NS
Mechanisms of gene expression control in the p53 network
$332,381Joaquin M. Espinosa · University Of Colorado Denver · R01 · FY2020 · CA
Mechanisms of gene expression control in the p53 network
$332,381Joaquin M. Espinosa · University Of Colorado Denver · R01 · FY2018 · CA
Mechanisms of gene expression control in the p53 network
$332,381Joaquin M. Espinosa · University Of Colorado Denver · R01 · FY2021 · CA
Pre-Clinical Core
$332,297William D Cress · H. Lee Moffitt Cancer Ctr & Res Inst · P01 · FY2021 · CA
Development of novel metastatic mouse models that recapitulate the major immune contexts of human colon cancer
$332,226Tyler E Jacks · Massachusetts Institute Of Technology · R01 · FY2020 · CA
Lineage specifiers governing pancreatic cancer growth and molecular subtype
$332,209Eric Lee Snyder · University Of Utah · R01 · FY2024 · CA
Sphingolipids, Dietary Fatty Acids, and Intestinal Pathophysiology
$332,080Ashley Jones Snider · University Of Arizona · R01 · FY2022 · DK
Inhibiting tumor growth and metastasis in highly aggressive breast cancers with centrosome amplification
$332,028Ozgur Sahin · Medical University Of South Carolina · R01 · FY2023 · CA
Binding-Induced Enzyme Activation for Prodrug Therapy of HER2 Variants
$331,920Shawn C Owen · Utah State Higher Education System--University Of Utah · R01 · FY2025 · EB
Engineer Biomimetic Microfluidic Models to Investigate and Reprogram Tumor Associated Neutrophils for Cancer Therapy
$331,891Xiaoping Bao · Purdue University · R37 · FY2024 · CA
Stem cell-based tissue engineering for myotendinous junction modeling and repair
$331,837Masatoshi Suzuki · University Of Wisconsin-Madison · R01 · FY2024 · AR